It is a pharma private limited company based in Vaijapur, Maharashtra, India, established in 2017.
2017 | Vaijapur, Maharashtra, India | ActiveAmyntas Pharma Private Limited, a active private limited company, was established on 14 February 2017 in Vaijapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U33302MH2017PTC291193. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Apoorva Amar Shedge (Director), Harshal Chandrakant Patil (Director), Sajjadali Riyasatali Syed (Director). Past directors included Faiza Kadarali Sayed, Kadarali Riyasatali Sayyed, Riyastali Azgarali Syed. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at H. No.873, Kazi Galli,, Vaijapur, Maharashtra, 423701.
U33302MH2017PTC291193
291193
14 February 2017
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Amyntas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Apoorva Amar Shedge | Director | 19 Sep 2024 | Current |
| Harshal Chandrakant Patil | Director | 19 Sep 2024 | Current |
| Sajjadali Riyasatali Syed | Director | 19 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 15 Nov 2022 | Past |
| Pramod Abcsdd | Director | 15 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amyntas Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 27.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Amyntas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Amyntas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amyntas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amyntas Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Apoorva Amar Shedge was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Harshal Chandrakant Patil was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
The activity Sajjadali Riyasatali Syed was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
Amyntas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Amyntas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
The activity Amyntas Pharma Private Limited was registered on 14 Feb 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records. was completed.
The CIN of Amyntas Pharma Private Limited is U33302MH2017PTC291193.
Amyntas Pharma Private Limited is headquartered at H. No.873, Kazi Galli,, Vaijapur, Maharashtra, 423701.
Amyntas Pharma Private Limited was incorporated on 14 February 2017.
The current directors of Amyntas Pharma Private Limited are
The primary industry of Amyntas Pharma Private Limited is Pharma.
Amyntas Pharma Private Limited is unlisted.
The authorized capital of Amyntas Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Amyntas Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX